Company / Tangible Book Value per Share
Vertex Pharmaceuticals Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$68.41
FY2025
5-year range
$35.01 / $68.41
FY2021-FY2025
Trend
+15.1%
vs FY2024
Sector context
#7 of 209
Health Care
What the data says
Among 209 Health Care companies, Vertex Pharmaceuticals is in the top 3% for tangible book value per share. Improved from $64.17 to $68.41 over the past 2 years.
Based on SEC 10-K filings.
68.41 in FY2025 with a 5-year CAGR of +18.2%. Top quartile in the Health Care sector.
Improved from $64.17 to $68.41 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +10.7%
- 5-Year CAGR
- +18.2%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 209This company $68.41 Sector average $93.47
▼
-26.8% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 15.1% year-over-year.
- Ranks #7 out of 209 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $68.41 | +15.1% |
| FY2024 | $59.46 | -7.3% |
| FY2023 | $64.17 | +27.3% |
| FY2022 | $50.40 | +44.0% |
| FY2021 | $35.01 | +18.0% |
| FY2020 | $29.67 | +49.0% |
| FY2019 | $19.92 | +15.1% |
| FY2018 | $17.31 | +117.3% |
| FY2017 | $7.97 | +77.4% |
| FY2016 | $4.49 | +22.1% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026